
The global market for Flibanserin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
It is a medication approved for the treatment ofÌýpre-menopausalÌýwomen withÌýhypoactive sexual desire disorderÌý(HSDD)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flibanserin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flibanserin API.
The Flibanserin API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flibanserin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flibanserin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sprout Pharmaceuticals
Chemodex Ltd.
Jigs Chemical
Century Pharma
Rakshit Drugs
by Type
>98%
>99%
by Application
Pharmaceutical
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flibanserin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Flibanserin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Flibanserin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Flibanserin API Market Overview
1.1 Product Definition
1.2 Flibanserin API by Type
1.2.1 Global Flibanserin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 >98%
1.2.3 >99%
1.3 Flibanserin API by Application
1.3.1 Global Flibanserin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.4 Global Market Growth Prospects
1.4.1 Global Flibanserin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Flibanserin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Flibanserin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Flibanserin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Flibanserin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Flibanserin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Flibanserin API, Industry Ranking, 2023 VS 2024
2.4 Global Flibanserin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Flibanserin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Flibanserin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Flibanserin API, Product Offered and Application
2.8 Global Key Manufacturers of Flibanserin API, Date of Enter into This Industry
2.9 Flibanserin API Market Competitive Situation and Trends
2.9.1 Flibanserin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Flibanserin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Flibanserin API Production by Region
3.1 Global Flibanserin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Flibanserin API Production Value by Region (2020-2031)
3.2.1 Global Flibanserin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Flibanserin API by Region (2026-2031)
3.3 Global Flibanserin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Flibanserin API Production Volume by Region (2020-2031)
3.4.1 Global Flibanserin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Flibanserin API by Region (2026-2031)
3.5 Global Flibanserin API Market Price Analysis by Region (2020-2025)
3.6 Global Flibanserin API Production and Value, Year-over-Year Growth
3.6.1 North America Flibanserin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Flibanserin API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Flibanserin API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Flibanserin API Production Value Estimates and Forecasts (2020-2031)
4 Flibanserin API Consumption by Region
4.1 Global Flibanserin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Flibanserin API Consumption by Region (2020-2031)
4.2.1 Global Flibanserin API Consumption by Region (2020-2025)
4.2.2 Global Flibanserin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Flibanserin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Flibanserin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Flibanserin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Flibanserin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Flibanserin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Flibanserin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Flibanserin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Flibanserin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Flibanserin API Production by Type (2020-2031)
5.1.1 Global Flibanserin API Production by Type (2020-2025)
5.1.2 Global Flibanserin API Production by Type (2026-2031)
5.1.3 Global Flibanserin API Production Market Share by Type (2020-2031)
5.2 Global Flibanserin API Production Value by Type (2020-2031)
5.2.1 Global Flibanserin API Production Value by Type (2020-2025)
5.2.2 Global Flibanserin API Production Value by Type (2026-2031)
5.2.3 Global Flibanserin API Production Value Market Share by Type (2020-2031)
5.3 Global Flibanserin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Flibanserin API Production by Application (2020-2031)
6.1.1 Global Flibanserin API Production by Application (2020-2025)
6.1.2 Global Flibanserin API Production by Application (2026-2031)
6.1.3 Global Flibanserin API Production Market Share by Application (2020-2031)
6.2 Global Flibanserin API Production Value by Application (2020-2031)
6.2.1 Global Flibanserin API Production Value by Application (2020-2025)
6.2.2 Global Flibanserin API Production Value by Application (2026-2031)
6.2.3 Global Flibanserin API Production Value Market Share by Application (2020-2031)
6.3 Global Flibanserin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Sprout Pharmaceuticals
7.1.1 Sprout Pharmaceuticals Flibanserin API Company Information
7.1.2 Sprout Pharmaceuticals Flibanserin API Product Portfolio
7.1.3 Sprout Pharmaceuticals Flibanserin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Sprout Pharmaceuticals Main Business and Markets Served
7.1.5 Sprout Pharmaceuticals Recent Developments/Updates
7.2 Chemodex Ltd.
7.2.1 Chemodex Ltd. Flibanserin API Company Information
7.2.2 Chemodex Ltd. Flibanserin API Product Portfolio
7.2.3 Chemodex Ltd. Flibanserin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Chemodex Ltd. Main Business and Markets Served
7.2.5 Chemodex Ltd. Recent Developments/Updates
7.3 Jigs Chemical
7.3.1 Jigs Chemical Flibanserin API Company Information
7.3.2 Jigs Chemical Flibanserin API Product Portfolio
7.3.3 Jigs Chemical Flibanserin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Jigs Chemical Main Business and Markets Served
7.3.5 Jigs Chemical Recent Developments/Updates
7.4 Century Pharma
7.4.1 Century Pharma Flibanserin API Company Information
7.4.2 Century Pharma Flibanserin API Product Portfolio
7.4.3 Century Pharma Flibanserin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Century Pharma Main Business and Markets Served
7.4.5 Century Pharma Recent Developments/Updates
7.5 Rakshit Drugs
7.5.1 Rakshit Drugs Flibanserin API Company Information
7.5.2 Rakshit Drugs Flibanserin API Product Portfolio
7.5.3 Rakshit Drugs Flibanserin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Rakshit Drugs Main Business and Markets Served
7.5.5 Rakshit Drugs Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Flibanserin API Industry Chain Analysis
8.2 Flibanserin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Flibanserin API Production Mode & Process Analysis
8.4 Flibanserin API Sales and Marketing
8.4.1 Flibanserin API Sales Channels
8.4.2 Flibanserin API Distributors
8.5 Flibanserin API Customer Analysis
9 Flibanserin API Market Dynamics
9.1 Flibanserin API Industry Trends
9.2 Flibanserin API Market Drivers
9.3 Flibanserin API Market Challenges
9.4 Flibanserin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Sprout Pharmaceuticals
Chemodex Ltd.
Jigs Chemical
Century Pharma
Rakshit Drugs
Ìý
Ìý
*If Applicable.
